Northeast Transplant Infectious Diseases Society (@northeasttxid) 's Twitter Profile
Northeast Transplant Infectious Diseases Society

@northeasttxid

Community of #TxID professionals in Northeastern USA. Interested in #TxID education & regional research collaboration. #idtwitter. acct managed by @rk3

ID: 1461141628022931456

calendar_today18-11-2021 01:19:14

136 Tweet

305 Followers

78 Following

Michael Ison, MD MS (@michaelgisonmd) 's Twitter Profile Photo

Excited to have our ESGICH-picked case as the next CPC! Join us at 3pm Central European Time ESCMID What do you think is the cause of fever and pancytopenia in this SOT recipient? Details: tts.org/tid-about/tid-… Register: us02web.zoom.us/webinar/regist…

Excited to have our ESGICH-picked case as the next CPC! Join us at 3pm Central European Time <a href="/ESCMID/">ESCMID</a> 

What do you think is the cause of fever and pancytopenia in this SOT recipient?

Details:  tts.org/tid-about/tid-…

Register:  us02web.zoom.us/webinar/regist…
maricar malinis (@maricar_malinis) 's Twitter Profile Photo

I am excited to be moderating this great case! TTS TransplantID Journal .As Alessandra Mularoni said it is a case with a twist. I am privileged to be working with experts in the field Priya Kodiyanplakkal, MD Professor Luppi Andrea Cona and Alessandra Mularoni. Please register.Details below:

maricar malinis (@maricar_malinis) 's Twitter Profile Photo

Thank you to our speakers. For those who missed it, the CPC will be posted on the tts.org/tid-education/… soon! Next CPC will be on 7/5. Mark your calendars!📅

Infectious Diseases Community of Practice - AST (@ast_idcop) 's Twitter Profile Photo

📢📢 Infectious Diseases Community of Practice - AST members! AmericanTransplantCongress in Philly is just around the corner! Are you interested in engaging with the next generation of leaders in TID? Be sure to sign up for the TID poster walk on 6/3 or 6/4 at 9:15am (both days). Check your recent email for sign up details! 📄

Sapna Amin Mehta MD (@sapnamehtamd) 's Twitter Profile Photo

Are you using the CMV immunity panel at your transplant center? Srijana Jonchhe sharing our experience to date from NYU Langone Health. Let’s keep sharing real world experience of this TxID tool. Division of Infectious Diseases & Immunology (ID)

Are you using the CMV immunity panel at your transplant center? Srijana Jonchhe sharing our experience to date from <a href="/nyulangone/">NYU Langone Health</a>. Let’s keep sharing real world experience of this TxID tool. <a href="/NYUGSOM_ID/">Division of Infectious Diseases & Immunology (ID)</a>
Infectious Diseases Community of Practice - AST (@ast_idcop) 's Twitter Profile Photo

IDWeek Invite! Interested in TxID and Immunocompromised Hosts?? Launching a new COP! The IDSA Immunocompromised Host Community of Practice Reception will take place on Thursday October 17th at 6pm. To RSVP please go to: idsa.tfaforms.net/147 IDWeek American Society of Transplantation (AST) IDSA

AST Trainee & Young Faculty COP (@ast_tyfcop) 's Twitter Profile Photo

Starting our @TYFCOP tweetorial series with CMV management strategies! ⭐️We know CMV management varies widely across transplant centers, often diverging from guidelines. Follow along to learn how to approach CMV disease in a solid organ transplant recipient 👀👀👀👀 1/13

maricar malinis (@maricar_malinis) 's Twitter Profile Photo

Today IDWeek with MURAT AKOVA and distinguished speakers David Fredericks, Tobias Hohl and Robert Jenq discussing GI microbiome in neutropenic patients @PergamIC #IDSA_IHCOP

Today <a href="/IDWeekmtg/">IDWeek</a> with <a href="/akovamurat/">MURAT AKOVA</a> and distinguished speakers David Fredericks, Tobias Hohl and Robert Jenq discussing GI  microbiome in neutropenic patients @PergamIC #IDSA_IHCOP
transplantid.net (@transplantidnet) 's Twitter Profile Photo

Maribavir v. GCV - Resistance! Subanalysis of pivotal maribavir trial Journal of Infectious Diseases Resistance: 💊More common w/ maribavir (10% v 2.5%) 💊Associated with VL ≥9100 IU/mL and refractory inf In R/R CMV w/ high VL, do you start with maribavir? Now in CMV 📁 transplantid.net/L7ERB7ET

Maribavir v. GCV - Resistance!

Subanalysis of pivotal maribavir trial <a href="/JIDJournal/">Journal of Infectious Diseases</a>
Resistance:
💊More common w/ maribavir (10% v 2.5%)
💊Associated with VL ≥9100 IU/mL and refractory inf

In R/R CMV w/ high VL, do you start with maribavir?

Now in CMV 📁

transplantid.net/L7ERB7ET